BIOELECTRONIC DEVICES WITH A SINGLE MOLECULE DETECTION LIMIT FOR RELIABLE AND LOW-COST RAPID SCREENING OF SYMPTOMATIC AND ASYMPTOMATIC COVID-19 SUBJECTS (Q4201956): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
| label / en | label / en | ||||||||||||||
BIOELECTRONIC DEVICES WITH A SINGLE MOLECULE DETECTION LIMIT FOR RELIABLE AND LOW-COST RAPID SCREENING OF SYMPTOMATIC AND ASYMPTOMATIC COVID-19 SUBJECTS | |||||||||||||||
| Property / summary | |||||||||||||||
BIOSCREEN PROPOSES A DIAGNOSTIC SYSTEM, VALIDATED IN A RELEVANT ENVIRONMENT, FOR IMMUNOLOGICAL SEROLOGICAL ANALYSIS, CONSISTING OF A SET OF INTEGRATED HARDWARE AND SOFTWARE COMPONENTS WITH A MODULAR APPROACH IDEAL FOR RELIABLE, FAST AND LOW-COST SCREENING OF A LARGE POPULATION OF SYMPTOMATIC AND ASYMPTOMATIC SUBJECTS AND SUBJECTS IMMUNISED AND NOT IMMUNISED TO SARS-COV-2 (COVID-19) AND ALSO APPLICABLE FOR FUTURE VIRAL EMERGENCIES.THE PROPOSED SOLUTION IS BASED ON THE NEW TECHNOLOGY SINGLE-MOLECULE-TRANSISTOR, DEVELOPED AND PATENTED BY UNIBS AND UNIBA PARTNERS, WHICH ALLOWS TO DETECT BIOLOGICAL EVENTS AT THE SINGLE MOLECULE. STARTING FROM THIS TECHNOLOGY, IN BIOSCREEN WE WILL DEVELOP RELIABLE, FAST AND LOW-COST DIAGNOSTIC DEVICES, WITH A FEMTO-MOLAR DETECTION LIMIT, THEREFORE 1000 TIMES BETTER THAN MORE COMPLEX, SLOW AND COSTLY TECHNOLOGIES AVAILABLE IN THE STATE OF THE ART. BIOSCREEN WILL TAKE CARE OF THE REALISATION OF TWO CLASSES OF D (English) | |||||||||||||||
| Property / summary: BIOSCREEN PROPOSES A DIAGNOSTIC SYSTEM, VALIDATED IN A RELEVANT ENVIRONMENT, FOR IMMUNOLOGICAL SEROLOGICAL ANALYSIS, CONSISTING OF A SET OF INTEGRATED HARDWARE AND SOFTWARE COMPONENTS WITH A MODULAR APPROACH IDEAL FOR RELIABLE, FAST AND LOW-COST SCREENING OF A LARGE POPULATION OF SYMPTOMATIC AND ASYMPTOMATIC SUBJECTS AND SUBJECTS IMMUNISED AND NOT IMMUNISED TO SARS-COV-2 (COVID-19) AND ALSO APPLICABLE FOR FUTURE VIRAL EMERGENCIES.THE PROPOSED SOLUTION IS BASED ON THE NEW TECHNOLOGY SINGLE-MOLECULE-TRANSISTOR, DEVELOPED AND PATENTED BY UNIBS AND UNIBA PARTNERS, WHICH ALLOWS TO DETECT BIOLOGICAL EVENTS AT THE SINGLE MOLECULE. STARTING FROM THIS TECHNOLOGY, IN BIOSCREEN WE WILL DEVELOP RELIABLE, FAST AND LOW-COST DIAGNOSTIC DEVICES, WITH A FEMTO-MOLAR DETECTION LIMIT, THEREFORE 1000 TIMES BETTER THAN MORE COMPLEX, SLOW AND COSTLY TECHNOLOGIES AVAILABLE IN THE STATE OF THE ART. BIOSCREEN WILL TAKE CARE OF THE REALISATION OF TWO CLASSES OF D (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: BIOSCREEN PROPOSES A DIAGNOSTIC SYSTEM, VALIDATED IN A RELEVANT ENVIRONMENT, FOR IMMUNOLOGICAL SEROLOGICAL ANALYSIS, CONSISTING OF A SET OF INTEGRATED HARDWARE AND SOFTWARE COMPONENTS WITH A MODULAR APPROACH IDEAL FOR RELIABLE, FAST AND LOW-COST SCREENING OF A LARGE POPULATION OF SYMPTOMATIC AND ASYMPTOMATIC SUBJECTS AND SUBJECTS IMMUNISED AND NOT IMMUNISED TO SARS-COV-2 (COVID-19) AND ALSO APPLICABLE FOR FUTURE VIRAL EMERGENCIES.THE PROPOSED SOLUTION IS BASED ON THE NEW TECHNOLOGY SINGLE-MOLECULE-TRANSISTOR, DEVELOPED AND PATENTED BY UNIBS AND UNIBA PARTNERS, WHICH ALLOWS TO DETECT BIOLOGICAL EVENTS AT THE SINGLE MOLECULE. STARTING FROM THIS TECHNOLOGY, IN BIOSCREEN WE WILL DEVELOP RELIABLE, FAST AND LOW-COST DIAGNOSTIC DEVICES, WITH A FEMTO-MOLAR DETECTION LIMIT, THEREFORE 1000 TIMES BETTER THAN MORE COMPLEX, SLOW AND COSTLY TECHNOLOGIES AVAILABLE IN THE STATE OF THE ART. BIOSCREEN WILL TAKE CARE OF THE REALISATION OF TWO CLASSES OF D (English) / qualifier | |||||||||||||||
point in time: 1 February 2022
| |||||||||||||||
Revision as of 06:31, 1 February 2022
Project Q4201956 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BIOELECTRONIC DEVICES WITH A SINGLE MOLECULE DETECTION LIMIT FOR RELIABLE AND LOW-COST RAPID SCREENING OF SYMPTOMATIC AND ASYMPTOMATIC COVID-19 SUBJECTS |
Project Q4201956 in Italy |
Statements
95,147.28 Euro
0 references
190,294.57 Euro
0 references
50.0 percent
0 references
INTERSAIL ENGINEERING S.R.L.
0 references
UNIVERSITÃ DEGLI STUDI DI BRESCIA
0 references
UNIVERSITÃ DEGLI STUDI DI BARI ALDO MORO
0 references
BIOSCREEN PROPONE UN SISTEMA DIAGNOSTICO, CONVALIDATO IN AMBIENTE RILEVANTE, PER ANALISI SIEROLOGICA IMMUNOLOGICA, COSTITUITO DA UN INSIEME DI COMPONENTI HARDWARE E SOFTWARE INTEGRATI CON UN APPROCCIO MODULARE IDEALE PER LO SCREENING AFFIDABILE, RAPIDO E A BASSO COSTO DI UN AMPIA POPOLAZIONE DI SOGGETTI SINTOMATICI ED ASINTOMATICI E DI SOGGETTI IMMUNIZZATI E NON IMMUNIZZATI AL SARS-COV-2 (COVID-19) ED APPLICABILE ANCHE PER EMERGENZE VIRALI FUTURE.LA SOLUZIONE PROPOSTA SI BASA SULLA NUOVISSIMA TECNOLOGIA ÂSINGLE-MOLECULE-TRANSISTORÂ, SVILUPPATA E BREVETTATA DAI PARTNER UNIBS E UNIBA, CHE PERMETTE DI RILEVARE EVENTI BIOLOGICI ALLA SINGOLA MOLECOLA. PARTENDO DA QUESTA TECNOLOGIA, IN BIOSCREEN SVILUPPEREMO DISPOSITIVI DIAGNOSTICI AFFIDABILI, VELOCI ED A BASSO COSTO, CON UN LIMITE DI RILEVAZIONE DEL FEMTO-MOLARE, QUINDI 1000 VOLTE MIGLIORE RISPETTO A TECNOLOGIE PIù COMPLESSE, LENTE E COSTOSE DISPONIBILI ALLO STATO DELL ARTE. BIOSCREEN SI OCCUPERà DELLA REALIZZAZIONE DI DUE CLASSI DI D (Italian)
0 references
BIOSCREEN PROPOSES A DIAGNOSTIC SYSTEM, VALIDATED IN A RELEVANT ENVIRONMENT, FOR IMMUNOLOGICAL SEROLOGICAL ANALYSIS, CONSISTING OF A SET OF INTEGRATED HARDWARE AND SOFTWARE COMPONENTS WITH A MODULAR APPROACH IDEAL FOR RELIABLE, FAST AND LOW-COST SCREENING OF A LARGE POPULATION OF SYMPTOMATIC AND ASYMPTOMATIC SUBJECTS AND SUBJECTS IMMUNISED AND NOT IMMUNISED TO SARS-COV-2 (COVID-19) AND ALSO APPLICABLE FOR FUTURE VIRAL EMERGENCIES.THE PROPOSED SOLUTION IS BASED ON THE NEW TECHNOLOGY SINGLE-MOLECULE-TRANSISTOR, DEVELOPED AND PATENTED BY UNIBS AND UNIBA PARTNERS, WHICH ALLOWS TO DETECT BIOLOGICAL EVENTS AT THE SINGLE MOLECULE. STARTING FROM THIS TECHNOLOGY, IN BIOSCREEN WE WILL DEVELOP RELIABLE, FAST AND LOW-COST DIAGNOSTIC DEVICES, WITH A FEMTO-MOLAR DETECTION LIMIT, THEREFORE 1000 TIMES BETTER THAN MORE COMPLEX, SLOW AND COSTLY TECHNOLOGIES AVAILABLE IN THE STATE OF THE ART. BIOSCREEN WILL TAKE CARE OF THE REALISATION OF TWO CLASSES OF D (English)
1 February 2022
0 references
BRESCIA
0 references
GUSSAGO
0 references